
© 2025 LYNX-Werbemitteilung - Bitte beachten Sie den Haftungsausschluss
Realtime | Geld | Brief | Zeit |
---|---|---|---|
716,20 | 716,60 | 16:52 | |
716,00 | 716,60 | 16:52 |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
16:18 | Healthcare Opportunities And Risks Collide For Direxion's Eli Lilly-Focused ELIL, ELIS ETFs | ||
10:18 | ASPEN PHARMACARE HOLDINGS LIMITED - Aspen Secures SAHPRA Approval for Mounjaro as a Chronic Weight Management Treatment | ||
Sa | Should Investors Buy Eli Lilly Stock? | ||
Fr | Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly | ||
Fr | Lilly's Omvoh shows improved outcomes in ulcerative colitis |